The patient access consolidation trend accelerates as vendors recognize AI-driven conversation as the missing link between scheduling and care coordination.

DexCare's acquisition of Mila Health marks a strategic inflection point in how patient access vendors are approaching the fragmented healthcare workflow. By folding conversational AI capabilities into its existing patient navigation platform, DexCare is essentially acknowledging a hard truth: scheduling software alone no longer justifies its market position. The question now is whether this move becomes a template for industry consolidation or merely one vendor's attempt to keep pace with evolving customer expectations.
On its surface, the deal appears logical. DexCare has built a reputation managing the front-door experience—helping health systems optimize patient scheduling and access workflows. Mila Health brings autonomous conversational agents that handle the minutiae of patient engagement: the reminder calls, the pre-visit questionnaires, the discharge follow-ups. Together, they theoretically eliminate the manual touch points that plague even the most sophisticated scheduling systems. In practice, this means fewer no-shows, better pre-visit preparation, and reduced clinician time spent on coordination tasks.
But the deeper significance lies in what this acquisition reveals about vendor strategy in the post-EHR consolidation era. Health systems have spent two decades integrating monolithic electronic health records systems, only to discover that EHRs themselves have become operational drag. They're not good at external communication. They're not good at intelligent automation. They're especially not good at the conversational layer that modern consumers—increasingly impatient with phone trees and web portals—now expect. DexCare's move signals that winning vendors must now own the full patient communication stack, not just the appointment-booking layer.
For health system leaders, this consolidation offers both opportunity and risk. The opportunity is obvious: fewer vendor relationships to manage, theoretically better data integration, and a single throat to choke for patient access accountability. Mila's conversational AI could meaningfully reduce the staffing burden on call centers and registration teams, particularly for routine coordination tasks. Early reports suggest these systems can handle 70-80% of interactions autonomously, escalating only complex scenarios to human staff.
The risk is vendor lock-in and the perpetual question of AI effectiveness in healthcare's messy reality. Conversational AI works well in controlled environments with consistent patient populations and straightforward workflows. It works less well with the Medicaid population, patients with limited digital literacy, or complex clinical scenarios where nuance matters. Health systems will need to carefully evaluate whether Mila's platform handles their specific population and case mix before fully committing.
This transaction also illustrates a troubling trend for best-of-breed vendors. Once upon time, health IT purchasing favored specialized point solutions—the best scheduling vendor, the best prior authorization vendor, the best patient engagement vendor. But the industry has learned that point solutions create data silos and operational friction. The vendors winning today are those that can offer integrated workflows across multiple functions. DexCare's acquisition spree (this is its second major acquisition) reflects confidence that integration and consolidation will continue driving purchasing decisions.
For vendors not participating in this consolidation wave, the competitive pressure intensifies. Standalone scheduling vendors and standalone care coordination platforms increasingly look vulnerable. The market is moving toward integrated platforms, and smaller vendors will either be acquired, partnered with larger platforms, or gradually squeezed out by customers consolidating vendor relationships.
Health system leaders should view this acquisition not just as a product update but as a signal of where the market is heading. The question isn't whether to adopt conversational AI in patient workflows—it's which vendor ecosystem will deliver it most reliably and integrate it most seamlessly with existing infrastructure.
Reporting basis: hitconsultant.net. Analysis by the HTC editorial desk.